Will you be treated for Locally Advanced Head and Neck Squamous Cell Carcinoma? Have you been cancer free for at least two years after previous treatment? If so, you may eligible to participate in a clinical research trial aimed to measure the level of ctDNA in the blood before and after treatment.

The purpose of this research study is to see if a video impacts parental opinions about adolescents and how we can best measure your opinions.

The study is being done to compare two ways of treating patients with a brain injury. At this time medical providers do not know if one way is better than the other. Both ways of treating patients are used in standard of care. None of the treatments in this study are investigational.

Do you have COPD and repeated breathing flares ending up in the hospital? If you are under the care of a doctor at UNC, you may be eligible for a research study to find out which of two medicines, roflumilast or azithromycin, can help your COPD control.

Have you traveled to a dengue, Zika or other arbovirus endemic area? Donate blood to aid in the development of vaccines! If you have ever lived in or traveled to tropical areas where arboviruses are common and suspect you may have been exposed to an arbovirus, please consider participating in our research study and donating some blood!

The purpose of this study is to investigate the health of former women's soccer players.

The purpose of this study is to understand provider perceptions of immediate postpartum LARC. This research will help further explain black-white differences in immediate postpartum LARC uptake.

This is a three-year research study for people with primary membranous nephropathy (primary MN). The study will test if combining belimumab and rituximab is effective in treating Primary MN.

The purpose of this study is to understand what moms think about all types of birth control, including immediate postpartum Long-Acting Reversible Contraception (LARC), and what they think about planning for pregnancy. This study will help further explain black-white differences in immediate postpartum LARC uptake.

The PALS program is a peer support program that aims to improve participation in lupus clinical trials through increased education and availability of information about clinical trials.